CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita. Issue 2 (November 2017) - Kasperkiewicz, Michael; Kalies, Kathrin; Pagel, Rene; Bieber, Katja; Zillikens, Detlef; Ludwig, Ralf J.